The United States of America, As Represented by the Secretary, Department of Health and Human Services

Thomas D Pfister

Tony Navas

Robert J Kinders

Ralph E Parchment

James Halpern Doroshow

James E Doroshow

Apurva K Srivastava

Allison M Marrero

Anti-CD133 monoclonal antibodies having advantageous properties, products, compositions and kits comprising the monoclonal antibodies, methods (processes) of making the monoclonal antibodies and related compositions, as well as methods of using the monoclonal antibodies in analytical, diagnostic and therapeutic applications.

Anti-CD133 monoclonal antibodies and related compositions and methods

Methods and compositions are described herein for assaying the presence or absence of pY1235-MET or a fragment thereof.

Anti-pY1235-MET immunological binding reagent

Anti-CD133 monoclonal antibodies having advantageous properties; products, compositions and kits comprising the monoclonal antibodies; methods (processes) of making the monoclonal antibodies and related compositions, as well as methods of using the monoclonal antibodies in analytical, diagnostic and therapeutic applications.

Monoclonal antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 (pT1989 ATR), antigen binding fragments, conjugates thereof, and the use of these antibodies, antigen binding fragments and conjugates are disclosed herein. Also disclosed are nucleic acids encoding these antibodies, vectors including these antibodies, and isolated host cells transformed with these nucleic acids and vectors. Methods are also disclosed for using these antibodies, such as to detect pT1989 ATR, or to determine the dose of an agent of use to treat a subject. The antibodies are also of use for identifying ATR inhibitors.

Growing community of inventors

Frederick, MD, United States of America

Thomas D Pfister